Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Rossetti

Showing results (121-130 of 126) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 126 results.
Transplantation|December 4, 2020
Veno-occlusive Disease in HSCT Patients: Consensus-based Recommendations for Risk Assessment, Diagnosis, and Management by the GITMO GroupFrancesca Bonifazi, Simona Sica, Alessia Angeletti, et al.
Nature Communications|June 10, 2017
A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of actionElena Campaner, Alessandra Rustighi, Alessandro Zannini, et al.
Acta Neuropathologica|May 8, 2019
RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomasPeter Wirthschaft, Julia Bode, Himanshu Soni, et al.
ACS Pharmacology & Translational Science|March 15, 2022
Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing ScreenMaria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, et al.
Blood|January 29, 2021
Nintedanib targets KIT D816V neoplastic cells derived from induced pluripotent stem cells of systemic mastocytosisMarcelo A S Toledo, Malrun Gatz, Stephanie Sontag, et al.
Molecular Informatics|October 13, 2023
A community effort in SARS-CoV-2 drug discoveryJohannes Schimunek, Philipp Seidl, Katarina Elez, et al.
Pageof 13

Showing results (121-130 of 126) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 126 results.
Transplantation|December 4, 2020
Veno-occlusive Disease in HSCT Patients: Consensus-based Recommendations for Risk Assessment, Diagnosis, and Management by the GITMO GroupFrancesca Bonifazi, Simona Sica, Alessia Angeletti, et al.
Nature Communications|June 10, 2017
A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of actionElena Campaner, Alessandra Rustighi, Alessandro Zannini, et al.
Acta Neuropathologica|May 8, 2019
RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomasPeter Wirthschaft, Julia Bode, Himanshu Soni, et al.
ACS Pharmacology & Translational Science|March 15, 2022
Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing ScreenMaria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, et al.
Blood|January 29, 2021
Nintedanib targets KIT D816V neoplastic cells derived from induced pluripotent stem cells of systemic mastocytosisMarcelo A S Toledo, Malrun Gatz, Stephanie Sontag, et al.
Molecular Informatics|October 13, 2023
A community effort in SARS-CoV-2 drug discoveryJohannes Schimunek, Philipp Seidl, Katarina Elez, et al.
Pageof 13